Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Rx costs’ top driver isn’t cancer. It’s weight-loss drugs, like GLP-1s Human Resources March 1, 2026 The medicine finest recognized for dramatic weight reduction are quietly turning into a flashpoint within the competitors for expertise, and…
